InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Wednesday, 05/09/2018 12:57:09 PM

Wednesday, May 09, 2018 12:57:09 PM

Post# of 108192
From Ken's bio on the CEO PR I liked this part the most, "From 2001 until 2004 he served as Vice President, Licensing and New Business Development in the pharmaceuticals group, and from 2004 until 2007 served as Worldwide Vice President, Franchise Development, Ortho-Clinical Diagnostics. He has been responsible for numerous licensing and/or research collaboration deals in oncology, metabolic disease, cardiovascular disease, CNS and women’s health, including the ex-U.S. license to Millennium Pharmaceutical’s VELCADE, a first-in-class, oncology therapeutic with peak reported sales outside the U.S. of approximately $1.8 billion."

I certainly want him to succeed here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News